Physician profile
Bo Wang
NPI 1083174379
$10,635.61
in general payments reported to CMS, 2019-2025
5 companies · $9,288 in 2025
The $9,288 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $148 · 2024: $1,200 · 2025: $9,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,239 · Grant: $4,167 · Food and Beverage: $2,140 · Education: $90.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,238.83 |
| Grant | $4,166.50 |
| Food and Beverage | $2,139.93 |
| Education | $90.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,658.24 | 2023-2025 | Micra, Pulseselect |
| Boston Scientific Corporation | $3,837.91 | 2024-2025 | Accolade Sr, Versacross Access Solution |
| Abbott Laboratories | $2,025.14 | 2025 | Ensite, Ensite Precision |
| Biosense Webster, INC. | $89.49 | 2025 | Carto 3 |
| Recordati_rare_diseases_inc. | $24.83 | 2025 | Enjaymo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bo Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.